Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn L Ward

Showing results (71-80 of 154) with videos related to

Pageof 16
Sort By:
Breast Cancer Research and Treatment|May 9, 2018
Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Benjamin Daniels, Belinda E Kiely, Sarah J Lord, et al.
BMC Cancer|July 22, 2016
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migrationSean S Q Ma, Sameer Srivastava, Estelle Llamosas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2009
MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosaNicholas J Hawkins, James H-F Lee, Justin J-L Wong, et al.
Asia-Pacific Journal of Clinical Oncology|May 27, 2017
Quality and impact of eviQ Cancer Treatments Online (www.eviq.org.au): the medical oncologist's perspectiveLydia P Y Loke, Tina Y T Chen, Craig R Lewis, et al.
The Lancet. Oncology|September 2, 2006
Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysisKent R Johnson, Clare Ringland, Barrie J Stokes, et al.
Australian Health Review : a Publication of the Australian Hospital Association|October 13, 2025
Pilot testing of the Research Impact Assessment FrameworkRobyn L Ward, Don Nutbeam, Wilfred Mijnhardt, et al.
European Journal of Gastroenterology & Hepatology|January 29, 2013
A correlation of the endoscopic characteristics of colonic laterally spreading tumours with genetic alterationsAndrew J Metz, Michael J Bourke, Alan Moss, et al.
The Oncologist|March 25, 2016
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter StudyEmily Y He, Nicholas J Hawkins, Gabriel Mak, et al.
Asia-Pacific Journal of Clinical Oncology|April 17, 2024
eviQ Cancer Treatments Online: Providing evidence-based information to improve cancer patient outcomesJulia V Shingleton, Brooke W Stapleton, Aisling P Kelly, et al.
BMJ Open|January 26, 2017
Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohortBenjamin Daniels, Sarah J Lord, Belinda E Kiely, et al.
Pageof 16

Showing results (71-80 of 154) with videos related to

Sort By:
Pageof 16
Breast Cancer Research and Treatment|May 9, 2018
Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016)Benjamin Daniels, Belinda E Kiely, Sarah J Lord, et al.
BMC Cancer|July 22, 2016
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migrationSean S Q Ma, Sameer Srivastava, Estelle Llamosas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 8, 2009
MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosaNicholas J Hawkins, James H-F Lee, Justin J-L Wong, et al.
Asia-Pacific Journal of Clinical Oncology|May 27, 2017
Quality and impact of eviQ Cancer Treatments Online (www.eviq.org.au): the medical oncologist's perspectiveLydia P Y Loke, Tina Y T Chen, Craig R Lewis, et al.
The Lancet. Oncology|September 2, 2006
Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysisKent R Johnson, Clare Ringland, Barrie J Stokes, et al.
Australian Health Review : a Publication of the Australian Hospital Association|October 13, 2025
Pilot testing of the Research Impact Assessment FrameworkRobyn L Ward, Don Nutbeam, Wilfred Mijnhardt, et al.
European Journal of Gastroenterology & Hepatology|January 29, 2013
A correlation of the endoscopic characteristics of colonic laterally spreading tumours with genetic alterationsAndrew J Metz, Michael J Bourke, Alan Moss, et al.
The Oncologist|March 25, 2016
The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter StudyEmily Y He, Nicholas J Hawkins, Gabriel Mak, et al.
Asia-Pacific Journal of Clinical Oncology|April 17, 2024
eviQ Cancer Treatments Online: Providing evidence-based information to improve cancer patient outcomesJulia V Shingleton, Brooke W Stapleton, Aisling P Kelly, et al.
BMJ Open|January 26, 2017
Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohortBenjamin Daniels, Sarah J Lord, Belinda E Kiely, et al.
Pageof 16